142 related articles for article (PubMed ID: 35616632)
1. An in vitro model for discovery of osteoclast specific biomarkers towards identification of racehorses at risk for catastrophic fractures.
Malek G; Richard H; Beauchamp G; Laverty S
Equine Vet J; 2023 May; 55(3):534-550. PubMed ID: 35616632
[TBL] [Abstract][Full Text] [Related]
2. Secreted tartrate-resistant acid phosphatase 5b is a Marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model.
Rissanen JP; Suominen MI; Peng Z; Halleen JM
Calcif Tissue Int; 2008 Feb; 82(2):108-15. PubMed ID: 18084692
[TBL] [Abstract][Full Text] [Related]
3. Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schonberg disease (type II autosomal dominant osteopetrosis).
Alatalo SL; Ivaska KK; Waguespack SG; Econs MJ; Väänänen HK; Halleen JM
Clin Chem; 2004 May; 50(5):883-90. PubMed ID: 15016726
[TBL] [Abstract][Full Text] [Related]
4. Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption.
Halleen JM; Tiitinen SL; Ylipahkala H; Fagerlund KM; Väänänen HK
Clin Lab; 2006; 52(9-10):499-509. PubMed ID: 17078477
[TBL] [Abstract][Full Text] [Related]
5. A Novel Sandwich ELISA for Tartrate-Resistant Acid Phosphatase 5a and 5b Protein Reveals that Both Isoforms are Secreted by Differentiating Osteoclasts and Correlate to the Type I Collagen Degradation Marker CTX-I In Vivo and In Vitro.
Mira-Pascual L; Patlaka C; Desai S; Paulie S; Näreoja T; Lång P; Andersson G
Calcif Tissue Int; 2020 Feb; 106(2):194-207. PubMed ID: 31654098
[TBL] [Abstract][Full Text] [Related]
6. Changes in RANKL and TRAcP 5b after discontinuation of denosumab suggest RANKL mediated formation of osteoclasts results in the increased bone resorption.
Sølling AS; Harsløf T; Jørgensen NR; Langdahl B
Osteoporos Int; 2023 Mar; 34(3):599-605. PubMed ID: 36543965
[TBL] [Abstract][Full Text] [Related]
7. Improved methods for testing antiresorptive compounds in human osteoclast cultures.
Rissanen JP; Ylipahkala H; Fagerlund KM; Long C; Väänänen HK; Halleen JM
J Bone Miner Metab; 2009; 27(1):105-9. PubMed ID: 19018457
[TBL] [Abstract][Full Text] [Related]
8. Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption.
Hannon RA; Clowes JA; Eagleton AC; Al Hadari A; Eastell R; Blumsohn A
Bone; 2004 Jan; 34(1):187-94. PubMed ID: 14751577
[TBL] [Abstract][Full Text] [Related]
9. Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.
Terpos E; de la Fuente J; Szydlo R; Hatjiharissi E; Viniou N; Meletis J; Yataganas X; Goldman JM; Rahemtulla A
Int J Cancer; 2003 Sep; 106(3):455-7. PubMed ID: 12845688
[TBL] [Abstract][Full Text] [Related]
10. Tartrate-resistant acid phosphatase 5b is a marker of osteoclast number and volume in RAW 264.7 cells treated with receptor-activated nuclear κB ligand.
Lv Y; Wang G; Xu W; Tao P; Lv X; Wang Y
Exp Ther Med; 2015 Jan; 9(1):143-146. PubMed ID: 25452790
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the activity of tartrate-resistant acid phosphatase isoform 5b in normal Chinese children--a novel marker for bone growth.
Chen CJ; Chao TY; Janckila AJ; Cheng SN; Ku CH; Chu DM
J Pediatr Endocrinol Metab; 2005 Jan; 18(1):55-62. PubMed ID: 15679069
[TBL] [Abstract][Full Text] [Related]
12. Tartrate-resistant acid phosphatase 5B circulates in human serum in complex with alpha2-macroglobulin and calcium.
Ylipahkala H; Halleen JM; Kaija H; Vihko P; Väänänen HK
Biochem Biophys Res Commun; 2003 Aug; 308(2):320-4. PubMed ID: 12901871
[TBL] [Abstract][Full Text] [Related]
13. Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity.
Janckila AJ; Takahashi K; Sun SZ; Yam LT
Clin Chem; 2001 Jan; 47(1):74-80. PubMed ID: 11148180
[TBL] [Abstract][Full Text] [Related]
14. [Tartrate resistant acid phosphatase--TRACP-5b as a modern bone resorption marker].
Nowak Z; Konieczna M; Saracyn M; Wańkowicz Z
Pol Merkur Lekarski; 2008 Apr; 24(142):351-4. PubMed ID: 18634372
[TBL] [Abstract][Full Text] [Related]
15. A novel immunoassay for the determination of tartrate-resistant acid phosphatase 5b from rat serum.
Alatalo SL; Peng Z; Janckila AJ; Kaija H; Vihko P; Vaananen HK; Halleen JM
J Bone Miner Res; 2003 Jan; 18(1):134-9. PubMed ID: 12510815
[TBL] [Abstract][Full Text] [Related]
16. TRACP 5b and CTX as osteological markers of delayed fracture healing.
Moghaddam A; Müller U; Roth HJ; Wentzensen A; Grützner PA; Zimmermann G
Injury; 2011 Aug; 42(8):758-64. PubMed ID: 21168135
[TBL] [Abstract][Full Text] [Related]
17. [The mechanism of TRACP 5b maturation].
Ohashi T; Ichimura S; Mochizuki Y; Miura T; Mogushi K; Ohashi W; Sato Y; Kojima R; Tanaka H; Igarashi Y; Nomura F; Katayama K; Miki T; Nishizawa Y
Rinsho Byori; 2007 Apr; 55(4):325-9. PubMed ID: 17511262
[TBL] [Abstract][Full Text] [Related]
18. Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption.
Halleen JM
Anticancer Res; 2003; 23(2A):1027-9. PubMed ID: 12820342
[TBL] [Abstract][Full Text] [Related]
19. A dried blood spot-based method to measure levels of tartrate-resistant acid phosphatase 5b (TRACP-5b), a marker of bone resorption.
Eick GN; Devlin MJ; Cepon-Robins TJ; Kowal P; Sugiyama LS; Snodgrass JJ
Am J Hum Biol; 2019 May; 31(3):e23240. PubMed ID: 30897260
[TBL] [Abstract][Full Text] [Related]
20. [Development for the determination of band 5b tartrate-resistant acid phosphatase activity in serum].
Uchida K; Nakanishi M; Yoh K
Rinsho Byori; 2001 Jan; 49(1):51-5. PubMed ID: 11215484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]